Table 2.
Incidence and Risk Factors of Recurrence of AIH after LT
| Center sites | Time period | Year | No. | Incidence | Time to recurrence, yr |
|---|---|---|---|---|---|
| Madrid, Spain62 | 1988–1996 | 1998 | 27 | 9 (33) | 2.6±1.5 |
| Birmingham, UK59 | NA | 1999 | 47 | 13 (28) | 2.4 (0.5–5.3) |
| Paris, France63 | 1985–1992 | 1999 | 15 | 3 (20) | 1.6 (1–2.5) |
| New York, US64 | 1988–1995 | 2000 | 24 | 6 (25) | 1.3±0.2 |
| Boston, US54 | 1983–1998 | 2000 | 12 | 5 (42) | NA |
| Rochester, US57 | 1985–1998 | 2001 | 41 | 7 (17) | 4.6±1 |
| Dallas, US60 | 1984–1998 | 2002 | 55 | 11 (20) | NA |
| Paris, France56 | 1985–1992 | 2003 | 17 | 7 (41) | 2.5±1.7 |
| Colorado, US55 | 1988–2006 | 2008 | 66 | 23 (34.8) | 4.3 |
| Alberta, Canada61 | NA | 2009 | 46 | 11 (24) | 4±1.3 |
| Birmingham, UK58 | 1999–2014 | 2016 | 69 | 5 (7) | 3.8 (1.5–7.3) |
Data are presented as number (%), mean±SD, or median (range).
AIH, autoimmune hepatitis; LT, liver transplantation; NA, not available.